D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 131.5 SEK -1.13% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Intrinsic Value

The intrinsic value of one DVYSR stock under the Base Case scenario is 124.25 SEK. Compared to the current market price of 131.5 SEK, Devyser Diagnostics AB is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DVYSR Intrinsic Value
124.25 SEK
Overvaluation 6%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
Devyser Diagnostics AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DVYSR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DVYSR?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Devyser Diagnostics AB

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Devyser Diagnostics AB

Provide an overview of the primary business activities
of Devyser Diagnostics AB.

What unique competitive advantages
does Devyser Diagnostics AB hold over its rivals?

What risks and challenges
does Devyser Diagnostics AB face in the near future?

Has there been any significant insider trading activity
in Devyser Diagnostics AB recently?

Summarize the latest earnings call
of Devyser Diagnostics AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Devyser Diagnostics AB.

Provide P/S
for Devyser Diagnostics AB.

Provide P/E
for Devyser Diagnostics AB.

Provide P/OCF
for Devyser Diagnostics AB.

Provide P/FCFE
for Devyser Diagnostics AB.

Provide P/B
for Devyser Diagnostics AB.

Provide EV/S
for Devyser Diagnostics AB.

Provide EV/GP
for Devyser Diagnostics AB.

Provide EV/EBITDA
for Devyser Diagnostics AB.

Provide EV/EBIT
for Devyser Diagnostics AB.

Provide EV/OCF
for Devyser Diagnostics AB.

Provide EV/FCFF
for Devyser Diagnostics AB.

Provide EV/IC
for Devyser Diagnostics AB.

Show me price targets
for Devyser Diagnostics AB made by professional analysts.

What are the Revenue projections
for Devyser Diagnostics AB?

How accurate were the past Revenue estimates
for Devyser Diagnostics AB?

What are the Net Income projections
for Devyser Diagnostics AB?

How accurate were the past Net Income estimates
for Devyser Diagnostics AB?

What are the EPS projections
for Devyser Diagnostics AB?

How accurate were the past EPS estimates
for Devyser Diagnostics AB?

What are the EBIT projections
for Devyser Diagnostics AB?

How accurate were the past EBIT estimates
for Devyser Diagnostics AB?

Compare the revenue forecasts
for Devyser Diagnostics AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Devyser Diagnostics AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Devyser Diagnostics AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Devyser Diagnostics AB compared to its peers.

Compare the P/E ratios
of Devyser Diagnostics AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Devyser Diagnostics AB with its peers.

Analyze the financial leverage
of Devyser Diagnostics AB compared to its main competitors.

Show all profitability ratios
for Devyser Diagnostics AB.

Provide ROE
for Devyser Diagnostics AB.

Provide ROA
for Devyser Diagnostics AB.

Provide ROIC
for Devyser Diagnostics AB.

Provide ROCE
for Devyser Diagnostics AB.

Provide Gross Margin
for Devyser Diagnostics AB.

Provide Operating Margin
for Devyser Diagnostics AB.

Provide Net Margin
for Devyser Diagnostics AB.

Provide FCF Margin
for Devyser Diagnostics AB.

Show all solvency ratios
for Devyser Diagnostics AB.

Provide D/E Ratio
for Devyser Diagnostics AB.

Provide D/A Ratio
for Devyser Diagnostics AB.

Provide Interest Coverage Ratio
for Devyser Diagnostics AB.

Provide Altman Z-Score Ratio
for Devyser Diagnostics AB.

Provide Quick Ratio
for Devyser Diagnostics AB.

Provide Current Ratio
for Devyser Diagnostics AB.

Provide Cash Ratio
for Devyser Diagnostics AB.

What is the historical Revenue growth
over the last 5 years for Devyser Diagnostics AB?

What is the historical Net Income growth
over the last 5 years for Devyser Diagnostics AB?

What is the current Free Cash Flow
of Devyser Diagnostics AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Devyser Diagnostics AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Devyser Diagnostics AB

Current Assets 258.9m
Cash & Short-Term Investments 171.4m
Receivables 49.5m
Other Current Assets 38m
Non-Current Assets 204m
PP&E 100m
Intangibles 82.9m
Other Non-Current Assets 21.1m
Current Liabilities 61.5m
Accounts Payable 10.1m
Accrued Liabilities 26.2m
Other Current Liabilities 25.2m
Non-Current Liabilities 52.4m
Long-Term Debt 47.5m
Other Non-Current Liabilities 4.9m
Efficiency

Earnings Waterfall
Devyser Diagnostics AB

Revenue
198m SEK
Cost of Revenue
-39.6m SEK
Gross Profit
158.4m SEK
Operating Expenses
-235.9m SEK
Operating Income
-77.5m SEK
Other Expenses
6.1m SEK
Net Income
-71.4m SEK

Free Cash Flow Analysis
Devyser Diagnostics AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DVYSR Profitability Score
Profitability Due Diligence

Devyser Diagnostics AB's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative ROE
28/100
Profitability
Score

Devyser Diagnostics AB's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

DVYSR Solvency Score
Solvency Due Diligence

Devyser Diagnostics AB's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
74/100
Solvency
Score

Devyser Diagnostics AB's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 146.63 SEK with a low forecast of 101 SEK and a high forecast of 201.6 SEK.

Lowest
Price Target
101 SEK
23% Downside
Average
Price Target
146.63 SEK
12% Upside
Highest
Price Target
201.6 SEK
53% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DVYSR?

Click here to dive deeper.

Dividends

Devyser Diagnostics AB
does not pay dividends
Shareholder Yield

Current shareholder yield for DVYSR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DVYSR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Devyser Diagnostics AB

Country

Sweden

Industry

Biotechnology

Market Cap

2.2B SEK

Dividend Yield

0%

Description

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

Contact

STOCKHOLM
Hagersten
Instrumentvagen 19
+46856215850
www.devyser.com

IPO

2021-12-10

Employees

75

Officers

Chief Executive Officer
Mr. Fredrik Alpsten
Chief Financial Officer
Ms. Sabina Berlin
Chief Scientific Officer
Mr. Michael Uhlin Ph.D.
Chief Human Resource Officer
Ms. Camilla Wiberg
Chief Commercial Officer
Mr. Theis Kipling
VP & GM of Devyser US
Mr. John Murad

See Also

Discover More
What is the Intrinsic Value of one DVYSR stock?

The intrinsic value of one DVYSR stock under the Base Case scenario is 124.25 SEK.

Is DVYSR stock undervalued or overvalued?

Compared to the current market price of 131.5 SEK, Devyser Diagnostics AB is Overvalued by 6%.

Back to Top